» Articles » PMID: 15194774

The VP7 Outer Capsid Protein of Rotavirus Induces Polyclonal B-cell Activation

Overview
Journal J Virol
Date 2004 Jun 15
PMID 15194774
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The early response to a homologous rotavirus infection in mice includes a T-cell-independent increase in the number of activated B lymphocytes in the Peyer's patches. The mechanism of this activation has not been previously determined. Since rotavirus has a repetitively arranged triple-layered capsid and repetitively arranged antigens can induce activation of B cells, one or more of the capsid proteins could be responsible for the initial activation of B cells during infection. To address this question, we assessed the ability of rotavirus and virus-like particles to induce B-cell activation in vivo and in vitro. Using infectious rotavirus, inactivated rotavirus, noninfectious but replication-competent virus, and virus-like particles, we determined that neither infectivity nor RNA was necessary for B-cell activation but the presence of the rotavirus outer capsid protein, VP7, was sufficient for murine B-cell activation. Preincubation of the virus with neutralizing VP7 antibodies inhibited B-cell activation. Polymyxin B treatment and boiling of the virus preparation were performed, which ruled out possible lipopolysaccharide contamination as the source of activation and confirmed that the structural conformation of VP7 is important for B-cell activation. These findings indicate that the structure and conformation of the outer capsid protein, VP7, initiate intestinal B-cell activation during rotavirus infection.

Citing Articles

Lack of evidence of rotavirus-dependent molecular mimicry as a trigger of coeliac disease.

Ziberna F, De Lorenzo G, Schiavon V, Arnoldi F, Quaglia S, De Leo L Clin Exp Immunol. 2016; 186(3):356-363.

PMID: 27548641 PMC: 5108075. DOI: 10.1111/cei.12855.


The improvement effects of edible bird's nest on proliferation and activation of B lymphocyte and its antagonistic effects on immunosuppression induced by cyclophosphamide.

Zhao R, Li G, Kong X, Huang X, Li W, Zeng Y Drug Des Devel Ther. 2016; 10:371-81.

PMID: 26855562 PMC: 4727516. DOI: 10.2147/DDDT.S88193.


Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species.

Vlasova A, Kandasamy S, Chattha K, Rajashekara G, Saif L Vet Immunol Immunopathol. 2016; 172:72-84.

PMID: 26809484 PMC: 4818210. DOI: 10.1016/j.vetimm.2016.01.003.


Rotavirus activates lymphocytes from non-obese diabetic mice by triggering toll-like receptor 7 signaling and interferon production in plasmacytoid dendritic cells.

Pane J, Webster N, Coulson B PLoS Pathog. 2014; 10(3):e1003998.

PMID: 24676425 PMC: 3968122. DOI: 10.1371/journal.ppat.1003998.


Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses.

Deal E, Lahl K, Narvaez C, Butcher E, Greenberg H J Clin Invest. 2013; 123(6):2464-74.

PMID: 23635775 PMC: 3668833. DOI: 10.1172/JCI60945.


References
1.
Parashar U, Hummelman E, Bresee J, Miller M, Glass R . Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003; 9(5):565-72. PMC: 2972763. DOI: 10.3201/eid0905.020562. View

2.
Burns J, Krishnaney A, Greenberg H . Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science. 1996; 272(5258):104-7. DOI: 10.1126/science.272.5258.104. View

3.
Stuker G, Oshiro L, SCHMIDT N . Antigenic comparisons of two new rotaviruses from rhesus monkeys. J Clin Microbiol. 1980; 11(2):202-3. PMC: 273357. DOI: 10.1128/jcm.11.2.202-203.1980. View

4.
Lopez D, Charyulu V, Sigel M . Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus. Cancer Res. 1981; 41(3):813-8. View

5.
Estes M, Graham D, Ramig R, Ericson B . Heterogeneity in the structural glycoprotein (VP7) of simian rotavirus SA11. Virology. 1982; 122(1):8-14. DOI: 10.1016/0042-6822(82)90372-5. View